688131.SS Overview

Company Profile

Shanghai Haoyuan Chemexpress Co., Ltd. engages in the research, development, and manufacture of pharmaceutical intermediates and small molecule drugs. It offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

Related stocks

300199.SZ

300199.SZ • China

23.71 CNY

3.13B USD 1Y +8.6%

002317.SZ

002317.SZ • China

ZHONGSHENGYAOYE

25.49 CNY

3.24B USD 1Y +50.3%

2096.HK

2096.HK • China

10.89 HKD

3.56B USD 1Y -13.7%

600518.SS

600518.SS • China

KANGMEI PHARMACEUTICAL CO LTD

1.35 CNY

2.79B USD 1Y -33.8%

000623.SZ

000623.SZ • China

17.53 CNY

3.14B USD 1Y -13.7%

300558.SZ

300558.SZ • China

48.43 CNY

3.07B USD 1Y -29.3%

300142.SZ

300142.SZ • China

14.75 CNY

3.53B USD 1Y +26%

300601.SZ

300601.SZ • China

KANGTAI BIOLOGICAL

13.44 CNY

2.25B USD 1Y -20.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

5 Metrics

Country

Region

Sector

Industry

Drug Manufacturers - Specialty & Generic

Website

https://www.chemexpress.cn

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

58.5% p.a.

Max Drawdown (5Y)

-85.5%

Sharpe Ratio (5Y)

-0.14

Beta Factor

0.66

Size Class

Large Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 High valuation risk: Avg P/E of 76.4 (Elevated multiple compression risk)

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (58.5% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -85.5% in the extended horizon.